Impact of Ad Exposure Frequency on Perception and Mental Processing of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Ads

OMB 0910-0803

Latest Forms, Documents, and Supporting Material

Document Name
SUPPORTING STATEMENT FINAL PART B 6-5-2015.docx Supporting Statement B
SUPPORTING STATEMENT FINAL PART A 6-5-2015.docx Supporting Statement A
Number of Completes, Main Study Other-Survey
Pretest 2 Completes Other-Survey
Pretest 1 Completes Other-Survey
Number of Main Study Screener Completes (assumes 10% eligible) Other-Survey
Pretest 2 Screener Completes (assumes 10% eligible) Other-Survey
Pretest 1 Screener Completes (assumes 10% eligible) Other-Survey